AI-generated summary
The authors report a randomized, double-blind, placebo-controlled trial comparing 650 nm and 780 nm low level laser therapy with placebo for preventing oral mucositis in patients undergoing hematopoietic cell transplantation. They found the 650 nm wavelength reduced the severity of oral mucositis and pain scores, and the therapy was well tolerated. The authors state that further study is needed to establish efficacy.
- Participants
- 70
- Who or what was studied
- Patients undergoing hematopoietic cell transplantation conditioned with chemotherapy or chemoradiotherapy
- Wavelengths
- 650, 780 nm
- Limits stated in the abstract
- The authors state that further study is needed to truly establish the efficacy of this mucositis prevention strategy.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 650 nm, 780 nm
- Energy density (fluence)
- 2 J/cm2
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Oral mucositis, Placebo-controlled, Wavelength, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.